Chronic Illness Articles
Despite education and intervention efforts, suicide rates are at a global all-time high. As surviving loved ones suffer, public health officials struggle to find solutions to a problem that is both pervasive and complex.
Findings from Grifols’ Phase IIb Alzheimer Management by Albumin Replacement (AMBAR) clinical trial found long-term plasmapheresis with albumin replacement reduced disease progression in a prespecified subset of patients with AD of moderate severity.
Until more is discovered about the causes of autoimmune disorders, these chronic but sometimes fatal disorders will continue to increase in numbers of diseases and individuals affected.
The right-to-die movement advocating the passage of state legislation to allow medical aid in dying is gaining momentum.
Private and public healthcare challenges grow as an aging population grapples with the ramifications of increasing numbers of HIV-positive senior citizens.
Central pain syndrome affects several million people worldwide, yet this condition wasn’t fully understood until recently, and there are still many challenges concerning diagnosis and treatment.
A physician diagnoses the condition and either treats it or refers the patient to someone else for treatment. End of story. Or is that just the beginning of the story? Narrative medicine challenges the medical model by bringing a new tool to the table: the story of the patient.
Seven case studies unveil some of the immunodeficiencies affecting seniors.
IVIG has enhanced and even saved the lives of many autoimmune disease patients. But, the cost of therapy, large dose size and limited raw materials are serious limitations to an otherwise efficacious, well-tolerated therapy.
Current treatments for PANDAS have been shown to be relatively effective, but could surgical treatments such as tonsillectomy and adenoidectomy offer more effective results?
Will the evolving therapeutic guidelines for treating diabetes, as well as managing its risks and complications, stem the tide of this costly and sometimes deadly disease?
For decades, donor blood stem cell transplantation has been the only potential cure for severe primary immunodeficiency disorders, but it has been limited by failure and serious complication risks. Now, a trifecta of scientific advances is transforming the prognosis for children once defenseless against life-threatening infections.